Apellis Pharmaceuticals
APLS
#3984
Rank
$2.22 B
Marketcap
$17.71
Share price
1.26%
Change (1 day)
-63.65%
Change (1 year)

P/S ratio for Apellis Pharmaceuticals (APLS)

P/S ratio as of April 2025 (TTM): 2.81

According to Apellis Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.62. At the end of 2024 the company had a P/S ratio of 5.20.

P/S ratio history for Apellis Pharmaceuticals from 2017 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.20-70.91%
202317.9-76.41%
202275.89.63%
202169.2300.1%
202017.3
2019N/A
2018N/A
2017N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA